Bill Title: As enacted, adds nonopioid medicinal drugs or drug products, occupational therapy, and interventional procedures or treatments to the alternative treatments that must be disclosed and explained by a healthcare practitioner to a patient or the patient's legal representative as a prerequisite to obtaining informed consent to treatment with an opioid. - Amends TCA Section 63-1-164.

Spectrum: Bipartisan Bill

Status: (Passed) 2020-03-26 - Pub. Ch. 573 [SB1912 Detail]

Text: Latest bill text (Chaptered) [PDF]

---

Voting Records

Chamber	Vote	Date	Yea	Nay	NV	Abs	Total	Result	Source	View
House	FLOOR VOTE: REGULAR CALENDAR PASSAGE ON THIRD CONSIDERATION	2020-03-05	87	0	0	0	87	Passed	Link	View
Senate	FLOOR VOTE: as Amended Third Consideration	2020-02-24	29	0	0	0	29	Passed	Link	View
Senate	SENATE HEALTH AND WELFARE COMMITTEE: Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 9, Nays 0 PNV 0	2020-02-19	9	0	0	0	9	Passed	Link	View

Social Comments on TN SB1912